Management of hypertension in chronic kidney disease

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Internal Medicine

Background:

• Optimal blood pressure control is a primary goal in managing chronic kidney disease (CKD).
• Despite its importance, achieving target blood pressure (<130/80 mm Hg) remains a challenge in clinical practice for CKD patients.
• Extracellular volume expansion is a significant factor contributing to hypertension in CKD.

Purpose of the Study:

• To outline strategies for achieving optimal blood pressure control in patients with chronic kidney disease.
• To highlight the importance of managing extracellular volume expansion.
• To discuss pharmacological interventions for hypertension in different stages of CKD.

Main Methods:

• Dietary salt restriction (100 mEq/d NaCl) to correct extracellular volume expansion.
• Use of thiazide diuretics for mild CKD and loop diuretics for advanced CKD.
• Application of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) for proteinuric CKD.
• Consideration of adding other antihypertensive classes when monotherapy is insufficient.

Main Results:

• Dietary salt restriction is a key initial step in managing volume expansion and hypertension.
• Diuretic choice (thiazide vs. loop) depends on CKD severity.
• ACEi and ARBs demonstrate efficacy in slowing CKD progression, particularly in proteinuric cases.
• Monotherapy with ACEi/ARBs often yields inadequate blood pressure control, necessitating combination therapy.

Conclusions:

• Effective management of extracellular volume is crucial for blood pressure control in CKD.
• A stepwise approach involving dietary changes, diuretics, and potentially combination antihypertensive therapy is required.
• Individualized treatment strategies are essential for optimizing hypertension management in CKD patients.